Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Teladoc HealthTDOC |
-$30M |
 |
DoximityDOCS |
-$1.57B |
 |
Veeva SystemsVEEV |
-$105M |
 |
Simulations PlusSLP |
-$2.06B |
 |
HealthequityHQY |
-$446M |
Are GoodRx Insiders Buying or Selling?
GoodRx (GDRX) has had 8 insider transactions in the past 90 days, all sells. The most recent was FRANCISCO PARTNERS IV, L.P., who sold 439,310 shares at $3.50 on August 26, 2026.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the GDRX AI Score. For government officials trading this stock, see GDRX congressional trading.
Who’s Trading GoodRx Stock?
| Insider | Activity | Trades | Last Trade |
|---|---|---|---|
| FRANCISCO PARTNERS IV, L.P. | Sold $5.5M | 8 | Aug 26, 2026 |
| Spectrum Equity VII, L.P. | Sold $250,000 | 8 | Oct 15, 2025 |
Recent GoodRx Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| FRANCISCO PARTNERS IV, L.P. | Aug 26, 2026 | Sell | 439,310 | $3.5 | $1.5M |
| FRANCISCO PARTNERS IV, L.P. | Aug 26, 2026 | Sell | 433,088 | $3.5 | $1.5M |
| FRANCISCO PARTNERS IV, L.P. | Aug 26, 2026 | Sell | 213,401 | $3.51 | $750,000 |
| FRANCISCO PARTNERS IV, L.P. | Aug 26, 2026 | Sell | 210,378 | $3.51 | $740,000 |
| FRANCISCO PARTNERS IV, L.P. | Aug 25, 2026 | Sell | 64,090 | $3.44 | $220,000 |
| FRANCISCO PARTNERS IV, L.P. | Aug 25, 2026 | Sell | 63,183 | $3.44 | $220,000 |
| FRANCISCO PARTNERS IV, L.P. | Aug 24, 2026 | Sell | 72,309 | $3.46 | $250,000 |
| FRANCISCO PARTNERS IV, L.P. | Aug 24, 2026 | Sell | 71,285 | $3.46 | $250,000 |
| Spectrum Equity VII, L.P. | Oct 15, 2025 | Sell | 15,202 | $4 | $61,000 |
| Spectrum Equity VII, L.P. | Oct 15, 2025 | Sell | 8,569 | $4 | $34,000 |
| Spectrum Equity VII, L.P. | Sep 5, 2025 | Sell | 10,243 | $4.05 | $41,000 |
| Spectrum Equity VII, L.P. | Sep 5, 2025 | Sell | 5,773 | $4.05 | $23,000 |
| Spectrum Equity VII, L.P. | Jul 3, 2025 | Sell | 6,828 | $4.8 | $33,000 |
| Spectrum Equity VII, L.P. | Jul 3, 2025 | Sell | 3,849 | $4.8 | $18,000 |
| Spectrum Equity VII, L.P. | Jun 6, 2025 | Sell | 6,828 | $4.09 | $28,000 |
| Spectrum Equity VII, L.P. | Jun 6, 2025 | Sell | 3,849 | $4.09 | $16,000 |
Frequently Asked Questions: GoodRx Insider Trading
In the past 90 days, GoodRx insiders have made 0 buys and 8 sells. The net selling may indicate insiders are taking profits or reducing exposure.
The most recent sale was by FRANCISCO PARTNERS IV, L.P. who sold 439,310 shares on August 26, 2026. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
FRANCISCO PARTNERS IV, L.P. has sold the most GDRX stock in the last 2 years, with a total value of $5.5M.
The total value of insider transactions for GoodRx in the last 2 years is negative, amounting to -$5.7M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
